Position in ARWR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$19,472,739
+$4,299,339 QoQ
Shares Held
238,900
-1.3% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#65
of 499 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. ARWR ranks #16 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
717,440 | $356,373,971 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
293,020 | $182,709,690 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
374,080 | $112,609,302 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
456,331 | $85,461,669 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,159,800 | $65,029,986 | |
| 6 | INSM |
INSMED Inc
|
593,512 | $63,280,249 | |
| 7 | INCY |
Incyte Corp
|
476,874 | $54,058,436 | |
| 8 | MRNA |
Moderna, Inc.
|
679,900 | $47,613,397 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,472,739 | 238,900 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $15,173,400 | 242,000 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $16,292,106 | 245,400 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $7,384,309 | 214,100 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,314,840 | 209,800 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,763,306 | 216,900 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $4,136,000 | 220,000 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,228,471 | 218,300 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $6,323,367 | 243,300 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $6,958,380 | 243,300 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $6,141,420 | 200,700 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $6,000,071 | 223,300 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,987,840 | 224,000 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,519,420 | 217,300 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $9,847,968 | 242,800 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $7,872,510 | 238,200 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $8,313,081 | 236,100 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $10,798,452 | 234,800 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $14,453,400 | 218,000 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $13,640,955 | 218,500 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $17,996,786 | 217,300 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $14,787,130 | 223,000 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $16,857,581 | 219,700 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $9,434,446 | 219,100 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $9,307,445 | 215,500 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $4,807,467 | 167,100 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||